• Oral steroids should be avoided in patients with bronchiectasis, unless there is a clear indication for an alternative comorbidity, such as asthma.
  • Although there is evidence for benefit of inhaled corticosteroids (ICS) for patients with COPD and elevated eosinophil counts, studies in bronchiectasis with eosinophilia are yet to report.
  • Patients with concomitant COPD and bronchiectasis should receive ICS in line with current COPD guidance.
  • Patients with isolated bronchiectasis and an eosinophilia may benefit from a trial of ICS. Advice from a bronchiectasis expert is strongly recommended.